Elevian Company
Elevian develops medicines that restore youthful regenerative capacity, with the potential to treat and prevent many age-related diseases.
Investors
Founded Date:
2017
Total Funding:
24333889
Investor Type:
Company
Employee Number:
1-10
Funding Status:
Seed
Number Of Exists:
Seed
Technology:
Regenerative Medicine
Last Funding Type:
Seed
Investors Number:
9
Last Funding Date:
2020
Industry:
Biopharma, Biotechnology
Headquarters:
Allston, Massachusetts, United States
Estimated Revenue:
$1M to $10M